Age- and sex-related changes in body weights and clinical pathology analytes in cynomolgus monkeys (Macaca Fascicularis) of Mauritius origin.


Journal

Veterinary clinical pathology
ISSN: 1939-165X
Titre abrégé: Vet Clin Pathol
Pays: United States
ID NLM: 9880575

Informations de publication

Date de publication:
Sep 2022
Historique:
revised: 04 11 2021
received: 08 09 2021
accepted: 11 11 2021
pubmed: 25 5 2022
medline: 15 9 2022
entrez: 24 5 2022
Statut: ppublish

Résumé

Clinical pathology and body weight information for the cynomolgus monkey in the literature is primarily derived from a small number of animals with limited age ranges, varying geographic origins, and mixed genders. This study aimed to summarize the age- and sex-related changes in clinical pathology analytes and body weights in cynomolgus monkeys of Mauritian origin. Pre-study age and body weight data were reviewed in 1819 animals, and pre-study hematologic, coagulation, and serum biochemical analytes were reviewed in 1664 animals. Body weights were statistically higher (P < 0.01) in males than females in all age groups (2-10 years). These measurements became prominent after 4 years of age and peaked at 7 to 8 years of age in both sexes. Sex-related differences were noted in reticulocyte (RETIC) counts, creatinine, cholesterol, and triglyceride concentrations, and alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) activities. Age-related differences were noted in RETIC and lymphocyte counts, creatinine, triglyceride, phosphorus, and globulin concentrations, and ALP and GGT activities. The youngest (2 to <3 year) age group had the fewest number of clinical pathologic analyte differences including ALP and GGT activity differences which occurred in all age groups from 2 to 10 years; they also had age-related lower globulin concentrations. There were no age- or sex-related differences in coagulation measurands. Sexual dimorphism in body weight was apparent for all ages from 2 to 10 years of age. The only difference in clinical pathology analytes unique to the 2 to <3 years of age group were age-related lower globulin levels.

Sections du résumé

BACKGROUND BACKGROUND
Clinical pathology and body weight information for the cynomolgus monkey in the literature is primarily derived from a small number of animals with limited age ranges, varying geographic origins, and mixed genders.
OBJECTIVES OBJECTIVE
This study aimed to summarize the age- and sex-related changes in clinical pathology analytes and body weights in cynomolgus monkeys of Mauritian origin.
METHODS METHODS
Pre-study age and body weight data were reviewed in 1819 animals, and pre-study hematologic, coagulation, and serum biochemical analytes were reviewed in 1664 animals.
RESULTS RESULTS
Body weights were statistically higher (P < 0.01) in males than females in all age groups (2-10 years). These measurements became prominent after 4 years of age and peaked at 7 to 8 years of age in both sexes. Sex-related differences were noted in reticulocyte (RETIC) counts, creatinine, cholesterol, and triglyceride concentrations, and alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) activities. Age-related differences were noted in RETIC and lymphocyte counts, creatinine, triglyceride, phosphorus, and globulin concentrations, and ALP and GGT activities. The youngest (2 to <3 year) age group had the fewest number of clinical pathologic analyte differences including ALP and GGT activity differences which occurred in all age groups from 2 to 10 years; they also had age-related lower globulin concentrations. There were no age- or sex-related differences in coagulation measurands.
CONCLUSIONS CONCLUSIONS
Sexual dimorphism in body weight was apparent for all ages from 2 to 10 years of age. The only difference in clinical pathology analytes unique to the 2 to <3 years of age group were age-related lower globulin levels.

Identifiants

pubmed: 35608195
doi: 10.1111/vcp.13094
pmc: PMC9541124
doi:

Substances chimiques

Globulins 0
Triglycerides 0
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

356-375

Informations de copyright

© 2022 The Authors. Veterinary Clinical Pathology published by Wiley Periodicals LLC on behalf of American Society for Veterinary Clinical Pathology.

Références

Vet Clin Pathol. 2012 Dec;41(4):441-53
pubmed: 23240820
Mem Inst Oswaldo Cruz. 2004 Oct;99(6):581-9
pubmed: 15558168
J Vet Med Sci. 2017 May 18;79(5):881-888
pubmed: 28381665
Exp Anim. 2002 Apr;51(2):125-31
pubmed: 12012719
Comp Med. 2016 Dec 1;66(6):480-488
pubmed: 28304252
Jikken Dobutsu. 1986 Oct;35(4):443-7
pubmed: 3803429
BMC Genomics. 2015 Mar 21;16:222
pubmed: 25887664
Lab Anim Res. 2019 Jul 24;35:7
pubmed: 32257895
J Reprod Dev. 2018 Aug 20;64(4):337-342
pubmed: 29848903
Lab Anim Res. 2016 Jun;32(2):79-86
pubmed: 27382375
J Med Primatol. 2013 Jun;42(3):120-31
pubmed: 23480663
Soc Psychol Personal Sci. 2017 May;8(4):355-362
pubmed: 28736600
Lipids Health Dis. 2016 Jun 24;15:111
pubmed: 27342143
PLoS One. 2014 Jan 08;9(1):e84599
pubmed: 24416248
Dev Cogn Neurosci. 2016 Dec;22:27-35
pubmed: 27833046
Nat Biotechnol. 2011 Oct 16;29(11):1019-23
pubmed: 22002653
Lab Anim Res. 2016 Mar;32(1):46-55
pubmed: 27051442
Exp Toxicol Pathol. 2006 Nov;58(2-3):77-88
pubmed: 16984807
Mol Ecol. 2008 Feb;17(4):1009-19
pubmed: 18261045
Vet Clin Pathol. 2022 Sep;51(3):356-375
pubmed: 35608195
J Med Primatol. 2009 Aug;38(4):228-35
pubmed: 19236562
PLoS One. 2013 Jun 10;8(6):e64892
pubmed: 23762263
Liver Int. 2016 Dec;36(12):1723-1734
pubmed: 27512925
Regul Toxicol Pharmacol. 2015 Oct;73(1):27-42
pubmed: 26111605
Front Endocrinol (Lausanne). 2015 Jan 19;5:241
pubmed: 25646091
Contemp Top Lab Anim Sci. 2002 Sep;41(5):18-20
pubmed: 12213042
Jikken Dobutsu. 1978 Oct;27(4):387-97
pubmed: 102516
Am J Primatol. 2014 Nov;76(11):1011-24
pubmed: 24990222
J Med Primatol. 1991 Sep;20(7):345-51
pubmed: 1787529
Regul Toxicol Pharmacol. 2012 Aug;63(3):391-400
pubmed: 22579626
J Med Primatol. 2014 Feb;43(1):1-10
pubmed: 24102586

Auteurs

Xiantang Li (X)

Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.

Dingzhou Li (D)

Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.

Kathleen E Biddle (KE)

Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.

Susan S Portugal (SS)

Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.

Mark R Li (MR)

Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.

Rosemary Santos (R)

Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.

John E Burkhardt (JE)

Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.

Nasir K Khan (NK)

Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH